Discover the significance of C. elegans in biological research, from Nobel Prize-winning discoveries to insights into gene ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

A novel molecular tool developed by a Lehigh University professor of biological sciences is enabling scientists to precisely ...

Skin allergies are often worsened by psychological stress, but the underlying mechanisms remain poorly understood.

Programmed cell death protein 1,” or PD-1, has been considered a key target in cancer therapies since its discovery in the ...

Cancer immunotherapy drugs called immune checkpoint inhibitors take the brakes off the body’s immune system, allowing it to ...

UC San Diego researchers reveal key differences in PD-1 checkpoint receptors between rodents and humans. Rodent PD-1 is ...

HX-009 is under clinical development by Waterstone Hanxbio and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase I drugs for Metastatic Melanoma have an 81% phase transition ...

HX-009 is under clinical development by Waterstone Hanxbio and currently in Phase II for Sarcomas. According to GlobalData, Phase II drugs for Sarcomas have a 27% phase transition success rate (PTSR) ...

Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments.

As the new year arrives, many will consider going on a diet to shed holiday weight. One popular approach might be ...